Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

COVID-19 can cause skin problems in children.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

COVID-19 can cause various skin issues, from mild rashes to severe conditions.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Type I interferons play a key role in the development of various skin diseases.

New treatments and understanding of skin lupus are emerging in 2024.

COVID-19 can harm many body parts, not just the lungs.

Beau's lines on nails may indicate severe COVID-19 or vaccination response.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Children with chilblain-like lesions may have a link to COVID-19.